Investing Profile

Geert-Jan Mulder

InvestorVC
Managing Partner at Managing Partner
forbion.comNaarden, Netherlands
Photo of Geert-Jan Mulder, Managing Partner at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Forbion Managing Partner
$100K - $5.0M
$1.5M
21
CompanyStageDateRound SizeTotal Raised
Citryll
Series BDec 2024$90M
$110M
Co-investors: Isabelle de Cremoux (Seventure Partners)
Mariana Oncology
Series BSep 2023$180M
$250M
Co-investors: Kevin Bitterman (Atlas Venture), Josh Resnick
Complement Therapeutics
Series AApr 2023$79M
SeedFeb 2022$6M
$85M
Co-investors: Dmitrij Hristodorov (Forbion)
Prilenia
Series BNov 2021$43M
Series AJun 2020$63M
$110M
AM Pharma
Series UnknownMar 2020$25M
Series FJul 2019$130M
Series CAug 2007$3M
$210M
Co-investors: Laia Crespo (Sanofi Ventures), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital)
Enterprise Therapeutics
Series BApr 2018$41M
$41M
Co-investors: Alexander Mayweg (Versant Ventures), David Morris
Exosome Diagnostics
Series CJul 2017$30M
Series BJan 2016$16M
Series BSep 2015$18M
Series BMar 2014$27M
Series AMay 2010$20M
$110M
Co-investors: Marco Boorsma (Forbion), Steven Soignet (Arcus Ventures)
Genetix Biotherapeutics Inc.
Series DJul 2012$60M
Series CApr 2011$30M
Series BMar 2010$35M
$130M
Co-investors: Philip Reilly (Third Rock Ventures), Steven Gillis (ARCH Venture Partners), Robert Tepper (Third Rock Ventures)